Schmid John P. is a director of AnaptysBio Inc.
Person profile
Roles
Address
San Diego, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Design Therapeutics, Inc.
25 Mar 24
4
Xeris Biopharma Holdings, Inc.
14 Mar 24
3
Helix Acquisition Corp. II
9 Feb 24
4
ANAPTYSBIO, INC
5 Jan 24
4
Xeris Biopharma Holdings, Inc.
17 Nov 23
4
Poseida Therapeutics, Inc.
16 Jun 23
4
Xeris Biopharma Holdings, Inc.
7 Jun 23
4
Design Therapeutics, Inc.
2 Jun 23
4
ANAPTYSBIO, INC
10 Jan 23
4
Poseida Therapeutics, Inc.
16 Jun 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
25 Mar 24 | DSGN Design Therapeutics | Common Stock | Buy | Acquire P | Yes | No | 3.74 | 17,809 | 66.61 k | 26,965 |
22 Mar 24 | DSGN Design Therapeutics | Common Stock | Buy | Acquire P | Yes | No | 3.6187 | 9,156 | 33.13 k | 9,156 |
14 Mar 24 | XERS Xeris Biopharma | Common Stock | Buy | Acquire P | Yes | No | 2.16 | 4,500 | 9.72 k | 11,000 |
3 Jan 24 | ANAB AnaptysBio | RSU Common Stock | Grant | Acquire A | No | No | 0 | 6,030 | 0.00 | 6,030 |
3 Jan 24 | ANAB AnaptysBio | Stock Option Common Stock | Grant | Acquire A | No | No | 21.19 | 16,510 | 349.85 k | 16,510 |
16 Nov 23 | XERS Xeris Biopharma | Common Stock | Buy | Acquire P | Yes | No | 1.51 | 6,500 | 9.82 k | 6,500 |